In vitro effects of propofol and volatile agents on pharmacologically induced chloride channel myotonia

Anesthesiology

Volumn 111, Issue 3, 2009, Pages 584-590

  Bandschapp, Oliver ^a   Ginz, Hans F ^a   Soule, Charles L ^b   Girard, Thierry ^a   Urwyler, Albert ^a   Iaizzo, Paul A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 ANTHROIC ACID; ACETAZOLAMIDE; CHLORIDE CHANNEL; DIMETHYL SULFOXIDE; HALOTHANE; INTRALIPID; ISOFLURANE; LIDOCAINE; PROCAINAMIDE; PROPOFOL; SEVOFLURANE; VOLATILE AGENT;

ARTICLE; BATH; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MEGADOSE; ELECTROSTIMULATION; GENERAL ANESTHESIA; HUMAN; IN VITRO STUDY; MAXIMUM PERMISSIBLE DOSE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MUSCLE CONTRACTURE; MYOTONIA; NONHUMAN; PRIORITY JOURNAL; RECTUS ABDOMINIS MUSCLE; SWINE; VAPORIZER;

EID: 69549110149     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181b05f23     Document Type: Article

References (35)

1. Driessen JJ: Neuromuscular and mitochondrial disorders: What is relevant to the anaesthesiologist? Curr Opin Anaesthesiol 2008; 21:350-355
2. Kinder Ross A: Muscular dystrophy versus mitochondrial myopathy: The dilemma of the undiagnosed hypotonic child. Paediatr Anaesth 2007; 17:1-6
3. Wolf A, Weir P, Segar P, Stone J, Shield J: Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 357:606-607
4. Pusch M: Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mutat 2002; 19:423-434
5. Newberg LA, Lambert EH, Gronert GA: Failure to induce malignant hyper-thermia in myotonic goats. Br J Anaesth 1983; 55:57-60
6. Lehmann-Horn F, Iaizzo PA: Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia? Br J Anaesth 1990; 65:692-697
7. Hayashida S, Yanagi F, Tashiro M, Terasaki H: [Anesthetic managements of a patient with congenital myotonia (Becker type)]. Masui 2004; 53:1293-1296
8. Johnson GW, Chadwick S, Eadsforth P, Hartopp I: Anaesthesia and myoto-nia. Br J Anaesth 1995; 75:113
9. Heiman-Patterson T, Martino C, Rosenberg H, Fletcher J, Tahmoush A: Malignant hyperthermia in myotonia congenita. Neurology 1988; 38:810-812
10. Moulds RF, Denborough MA: Procaine in malignant hyperpyrexia. Br Med J 1972; 4:526-528
11. Nelson TE, Austin KL, Denborough MA: Screening for malignant hyper-pyrexia. Br J Anaesth 1977; 49:169-172
12. Larach MG: Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-515
13. Iaizzo PA, Wedel DJ, Gallagher WJ: In vitro contracture testing for determination of susceptibility to malignant hyperthermia: A methodologic update. Mayo Clin Proc 1991; 66:998-1004
14. Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurds-son S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F: In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997; 41:955-966
15. Segal SS, Faulkner JA: Temperature-dependent physiological stability of rat skeletal muscle in vitro. Am J Physiol 1985; 248:C265-70
16. Cooper TE, Trezek GJ: Correlation of thermal properties of some human tissue with water content. Aerosp Med 1971; 42:24-27
17. Dutka TL, Murphy RM, Stephenson DG, Lamb GD: Chloride conductance in the transverse tubular system of rat skeletal muscle fibres: Importance in excitation-contraction coupling and fatigue. J Physiol 2008; 586:875-887
18. Kwieciński H, Lehmann-Horn F, Rüdel R: Drug-induced myotonia in human intercostal muscle. Muscle Nerve 1988; 11:576-581
19. Iaizzo PA, Lehmann-Horn F: The correlation between electrical after-activity and slowed relaxation in myotonia. Muscle Nerve 1990; 13:240-246
20. Marsch SC, Schaefer HG: External ophthalmoplegia after total intravenous anaesthesia. Anaesthesia 1994; 49:525-527
21. Borgeat A, Dessibourg C, Rochani M, Suter PM: Sedation by propofol in tetanus-is it a muscular relaxant? Intensive Care Med 1991; 17:427-429
22. Ummenhofer WC, Kindler C, Tschalèr G, Hampl KF, Drewe J, Urwyler A: Propofol reduces succinylcholine induced increase of masseter muscle tone. Can J Anaesth 1998; 45:417-423
23. Eguchi H, Tsujino A, Kaibara M, Hayashi H, Shirabe S, Taniyama K, Eguchi K: Acetazolamide acts directly on the human skeletal muscle chloride channel. Muscle Nerve 2006; 34:292-297
24. Ruff RL: Sour on the inside, calm on the outside: How acetazolamide may stabilize membrane excitability. Muscle Nerve 2006; 34:263-264
25. Haeseler G, Störmer M, Bufler J, Dengler R, Hecker H, Piepenbrock S, Leuwer M: Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg 2001; 92:1192-1198
26. Haeseler G, Karst M, Foadi N, Gudehus S, Roeder A, Hecker H, Dengler R, Leuwer M: High-affinity blockade of voltage-operated skeletal muscle and neuro-nal sodium channels by halogenated propofol analogues. Br J Pharmacol 2008; 155:265-275
27. Chen Z, Ong BH, Kambouris NG, Marbán E, Tomaselli GF, Balser JR: Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels. J Physiol 2000; 524(Pt 1):37-49
28. Zamponi GW, Sui X, Codding PW, French RJ: Dual actions of procain-amide on batrachotoxin-activated sodium channels: Open channel block and prevention of inactivation. Biophys J 1993; 65:2324-2334
29. + release by skeletal muscle sarcoplasmic reticulum: Differing sensitivity to inhalational anesthetics. Anesthesiology 1988; 69:571-577
30. + channels. Anesthesiology 2007; 107:91-98
31. + channel defect causes myotonia. Muscle Nerve 1990; 13: 528-535
32. Haberer JP, Fabre F, Rose E: Malignant hyperthermia and myotonia con-genita (Thomsen's disease). Anaesthesia 1989; 44:166
33. White RJ, Bass SP: Myotonic dystrophy and paediatric anaesthesia. Paediatr Anaesth 2003; 13:94-102
34. Michel P, Sternberg D, Jeannet PY, Dunand M, Thonney F, Kress W, Fontaine B, Fournier E, Kuntzer T: Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders. Muscle Nerve 2007; 36:643-650
35. Moxley RT 3rd, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT 4th, Barbieri CA, Dilek N, Wiegner AW, Thornton CA: Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1). Muscle Nerve 2007; 36:320-328